Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now full pipeline small index

Fuchs Endothelial Dystrophy: full-pipeline trial registry

6 of 8 indexed Fuchs Endothelial Dystrophy trials are currently recruiting.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 6 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Fuchs Endothelial Dystrophy: 8 US clinical trials tracked, 6 recruiting.

Fuchs Endothelial Dystrophy is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Cornea Research Foundation of America, running 1 of these trials.

Enrollment posture brief

Registry condition fuchs-endothelial-dystrophy

OPEN 6 | RECR 75% | LATE 2 | EARLY 2 | RANK #2176 | SPON 1

Nearest open-share peer: Adolescent Idiopathic Scoliosis (75% recruiting · 8 trials)

Activity, Motor75%Fuchs Endothelial Dystro (th…75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%
Open-enrollment share among volume-matched conditions near Fuchs Endothelial Dystrophy

Fuchs Endothelial Dystrophy lists 6 open slots (75% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Fuchs Endothelial Dystrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Fuchs Endothelial Dystrophy is recruiting above its size-band peers.

    6 of 8 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Fuchs Endothelial Dystrophy trials is spread across many organizations.

    Cornea Research Foundation of America accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Most Fuchs Endothelial Dystrophy trials plan to enrol fewer than 100 people.

    Median target enrolment is 72 among the 8 trials that report a genuine target (sentinel values excluded). 5 of those (62.5%) plan for fewer than 100 participants.

  4. Fuchs Endothelial Dystrophy research is mostly interventional.

    6 interventional and 2 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 31Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on Fuchs Endothelial Dystrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Descemet's stripping endothelial keratoplasty Procedure
1 trials
Netarsudil 0.02% Ophthalmic Solution Drug
1 trials
PRGF Biological
1 trials
Endothelial keratoplasty Procedure
1 trials
Ripasudil hydrochloride hydrate 0.4% ophthalmic solution Drug
1 trials
Ripasudil Drug
1 trials
Brillouin imaging Procedure
1 trials
Descemet Membrane Endothelial Keratoplasty Procedure
1 trials

US sites by state

Facility locations filed on Fuchs Endothelial Dystrophy trials. A trial with sites in several states counts in each.

Oregon 2 trials
Massachusetts 2 trials
Indiana 2 trials
Florida 2 trials
Pennsylvania 1 trials
Ohio 1 trials
New Hampshire 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Fuchs Endothelial Dystrophy page

8 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Fuchs Endothelial Dystrophy condition card totals 8 registered trials; most-linked intervention Descemet's stripping endothelial keratoplasty; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.